<SEC-DOCUMENT>0001193125-12-008506.txt : 20120111
<SEC-HEADER>0001193125-12-008506.hdr.sgml : 20120111
<ACCEPTANCE-DATETIME>20120111075834
ACCESSION NUMBER:		0001193125-12-008506
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20120111
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20120111
DATE AS OF CHANGE:		20120111

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MELA SCIENCES, INC. /NY
		CENTRAL INDEX KEY:			0001051514
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				133986004

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-51481
		FILM NUMBER:		12521114

	BUSINESS ADDRESS:	
		STREET 1:		50 SOUTH BUCKHOUT STREET
		STREET 2:		SUITE 1
		CITY:			IRVINGTON
		STATE:			NY
		ZIP:			10533
		BUSINESS PHONE:		914-591-3783

	MAIL ADDRESS:	
		STREET 1:		50 SOUTH BUCKHOUT STREET
		STREET 2:		SUITE 1
		CITY:			IRVINGTON
		STATE:			NY
		ZIP:			10533

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ELECTRO OPTICAL SCIENCES INC /NY
		DATE OF NAME CHANGE:	19971216
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d281251d8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML><HEAD>
<TITLE>Form 8-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="line-height:0px;margin-top:0px;margin-bottom:0px;border-bottom:0.5pt solid #000000">&nbsp;</P>
<P STYLE="line-height:3px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000">&nbsp;</P> <P STYLE="margin-top:4px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>UNITED STATES </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>SECURITIES AND EXCHANGE COMMISSION </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="3"><B>Washington, D.C. 20549 </B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center>
<P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>FORM 8-K
</B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center> <P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="4"><B>CURRENT REPORT </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="3"><B>Pursuant to Section&nbsp;13 or 15(d) of the </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Securities Exchange Act of
1934 </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Date of Report (Date of earliest event reported): January&nbsp;11, 2012 </B></FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center> <P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="6"><B>MELA Sciences, Inc. </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>(Exact name of registrant as specified in its charter) </B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center>
<P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Delaware</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>000-51481</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>13-3986004</B></FONT></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(State or other jurisdiction</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>of incorporation)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(Commission</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>File Number)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(IRS Employer</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>Identification No.)</B></FONT></P></TD></TR>
<TR>
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" COLSPAN="3" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>50 South Buckhout Street, Suite 1</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Irvington, New York</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>10533</B></FONT></TD></TR>
<TR>
<TD VALIGN="top" COLSPAN="3" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(Address of principal executive offices)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(Zip Code)</B></FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Registrant&#146;s telephone number, including area code (914)&nbsp;591-3783 </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(Former name or former address, if changed since last report.)
</B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center> <P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instructions A.2. below): </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Written communications pursuant to Rule&nbsp;425 under the Securities Act (17 CFR 230.425) </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Soliciting material pursuant to Rule&nbsp;14a-12 under the Exchange Act (17 CFR 240.14a-12) </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Pre-commencement communications pursuant to Rule&nbsp;14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Pre-commencement communications pursuant to Rule&nbsp;13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </FONT></TD></TR></TABLE>
<P STYLE="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="line-height:0px;margin-top:0px;margin-bottom:0px;border-bottom:0.5pt solid #000000">&nbsp;</P>
<P STYLE="line-height:3px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Item&nbsp;1.01 &#151; Entry into a Material Definitive Agreement </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px;padding-bottom:0px;"><FONT STYLE="font-family:Times New Roman" SIZE="2">On January&nbsp;11, 2012, MELA Sciences, Inc. (the &#147;Company&#148;) issued a press release announcing that it has entered into a
master production agreement (the &#147;Production Agreement&#148;) with Askion GmbH, a German company (&#147;Askion&#148;). Under the terms of the Production Agreement, Askion will manufacture and test certain components of the Company&#146;s
MelaFind<FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT> system, including the hand-held imaging device. Askion will also assemble and test the integrated
finished MelaFind<FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT> system, including the cart, for units to be sold within the European Union. In addition,
Askion will perform certain other services for the Company, such as warehousing, labeling, shipping, service and repair. The Company will provide Askion with purchase orders setting forth, among other things, the component and amount to be produced
or the service to be rendered along with the purchase price to be paid. The Production Agreement has an initial term of three years, unless earlier terminated by either party in accordance with its terms, and shall renew for successive three year
periods, unless one party notifies the other of its intention not to renew the Production Agreement. The Production Agreement replaces in its entirety the production agreement between the Company and Askion dated as of January&nbsp;25, 2006. A copy
of the press release is attached as Exhibit 99.1 to this current report. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Item&nbsp;9.01 &#151; Financial Statements and Exhibits
</B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">(d) Exhibits </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1px solid #000000;width:23pt" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1">Exhibit<BR>No.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:37pt"><FONT STYLE="font-family:Times New Roman" SIZE="1">Description</FONT></P></TD></TR>


<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">99.1</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">MELA Sciences, Inc. Press Release dated January&nbsp;11, 2012</FONT></TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>SIGNATURES </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE">


<TR>
<TD WIDTH="47%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="3%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="3"><FONT STYLE="font-family:Times New Roman" SIZE="2">MELA Sciences, Inc.</FONT></TD></TR>
<TR>
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Date: January&nbsp;11, 2012</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">By:</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">/s/ Richard I. Steinhart</FONT></P></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Richard I. Steinhart,</FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Chief
Financial Officer</FONT></P></TD></TR>
</TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d281251dex991.htm
<DESCRIPTION>PRESS RELEASE
<TEXT>
<HTML><HEAD>
<TITLE>Press Release</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Exhibit 99.1 </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g281251ex99_1.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>MELA Sciences Expands Manufacturing Contract </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">IRVINGTON, NY, January&nbsp;11, 2012 &#151; MELA Sciences, Inc. (NASDAQ: MELA) today announced that it has entered into an expanded three-year
manufacturing agreement with its long-term supplier, Askion GmbH, for the production of the MelaFind handheld device. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">MelaFind is the
Company&#146;s breakthrough non-invasive and objective automated point of care system for use when a dermatologist chooses to obtain additional information for a decision to biopsy clinically atypical pigmented skin lesions with one or more clinical
or historical characteristics of melanoma. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#147;We have enjoyed a fruitful collaboration with Askion since 2005. Askion has built systems to
support the initial launch of MelaFind and is currently building inventory for the early commercialization effort. This agreement provides for a secure supply of MelaFind handheld devices for the next three years,&#148; said Joseph V. Gulfo, MD,
President and CEO of MELA Sciences, Inc. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company is preparing for commercial launch in the U.S. and the European Union, initially in
Germany, which remains on track for the first quarter of 2012. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>About MELA Sciences, Inc. </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">MELA Sciences is a medical device company focused on the design, development and commercialization of non-invasive tools to provide additional information
to dermatologists during melanoma skin examinations. The Company&#146;s flagship product, MelaFind(R), is intended to be used when a trained dermatologist chooses to obtain additional information to help decide whether to biopsy certain
indeterminate pigmented skin lesions. MelaFind has received approval from the U.S. Food and Drug Administration and is approved for use in the U.S. In addition, MelaFind has received the CE Mark and is approved for use in the European Union.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">For more information on MELA Sciences, visit <U>www.melasciences.com</U>. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Safe Harbor </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">This press release includes &#147;forward-looking statements&#148; within the
meaning of the Securities Litigation Reform Act of 1995. These statements include but are not limited to our plans, objectives, expectations and intentions and other statements that contain words such as &#147;expects,&#148;
&#147;contemplates,&#148; &#147;anticipates,&#148; </FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
&#147;plans,&#148; &#147;intends,&#148; &#147;believes,&#148; &#147;assumes,&#148; &#147;predicts&#148; and variations of such words or similar expressions that predict or indicate future events
or trends, or that do not relate to historical matters. These statements are based on our current beliefs or expectations and are inherently subject to significant known and unknown uncertainties and changes in circumstances, many of which are
beyond our control. There can be no assurance that our beliefs or expectations will be achieved. Actual results may differ materially from our beliefs or expectations due to financial, economic, business, competitive, market, regulatory and
political factors or conditions affecting the company and the medical device industry in general, as well as more specific risks and uncertainties facing the company such as those set forth in its reports on Forms 10-Q and 10-K filed with the U.S.
Securities and Exchange Commission (the &#147;SEC&#148;). Factors that might cause such a difference include whether Melafind(R) achieves market acceptance or becomes commercially viable. Given the uncertainties affecting companies in the medical
device industry such as the Company, any or all of these forward-looking statements may prove to be incorrect. Therefore, you should not rely on any such factors or forward-looking statements. The Company urges you to carefully review and consider
the disclosures found in its filings with the SEC which are available at <U>www.sec.gov</U> and <U>www.melasciences.com</U>. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">For further
information contact: </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">For Investors </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Lynn Pieper </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Westwicke Partners, Ltd.
</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">415-202-5678 </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">For Media </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Melissa Hurley </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Ricochet Public Relations
</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">212-679-3300 x128 </FONT></P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g281251ex99_1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g281251ex99_1.jpg
M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D
M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$"
M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#_\``$0@`;P$M`P$1``(1`0,1`?_$`/$```(!`P4!````````
M```````*"08("P$"`P0'!0$``@$%`0$```````````````@'`0(#!@D%!!``
M``4#`@($!`P."0\-`0```0(#!`4`!@<1""$2,4$3"5$B%`IA<3(5U196EA=W
M6!J!D<&R(S-ST]25M5<X.:%"LY0E=K:7&-%B<I+24V.3)#0UQ2:&M_"Q4H*#
MHU1%948GIT@9$0`!`@0#`P4(#`L(`@$%```!`@,`$00%(1(&,4$'46%Q$Q2!
MD;'1(C*2"*'!0E*R(U-SDU05-N%B<M(S=#55%A<8\(+"8[,D=3>B-"7B0X-$
M)__:``P#`0`"$0,1`#\`GH[Q/ONK#VIWC.84PK;#7*N6X5!%&XIARZ!.S[&E
MW!#'-&/]"F";EF1>47#4IT12`Q=3#S<)ZX9<"+SKRC1<[NOL=H*BI*C@I4MA
M'*(C35G$>@L"G+10@/7-L8C:G&%P<G][#NRRQ<)[DN-/$2#PRQ5BIQN/3-D2
M`4VI$S%&<5%02ET`3:^,-,W:N#&C:6D-*\JN4ZA.7,'9`RW^:8A=WB/?W'%.
M9&!F),LFSV8DFV%]_3=EGW-!XQW76S:0XXE';6,C\AV+!C;ZMDBLH"8/KBC/
M*WYI>.Y1^RJ@HB")2\P@-1EQ(]7NGJ*!=ZTH^ZY7(;DIA:LRM\P#(3,HWC1_
M%AE%8S:[TA*$N"6=*9"?M0X#`2T7/PT;.0CYO*0TRR:R<5)-%"JMG\>^;IN&
MCM!0O`R:R*@&#P:Z4G!9<IE*IGDJ0\VHI4#@00<1$\I6'$AQ)!0H3!&\'9'U
MZI%T%$$%$$;#CH41T$>)0`"AJ(B8P%``Z.L:)@8G9%",PD-L+C=Z%WU\;MXN
MF>P#MFBK>OK)T<B5K>-\7`V+,V5:+U4H%/")1A5D"S\BDD)BK\JR7DZP"40'
MEID^%?`^OU51)U/?RNFLJ5>0D'*XX>82F!$3Z\XG,6A7V7:TAVZ2\N8FA*>7
M=,PNU']Y[NGCKF&[D/@G++B\\M`JE@"JS[<5.U,/DX31/L?:\>77@'"F+?X/
M:,<IDI2:_K0!_P#=_P#IB(F^(=^;=ZY26,A_R_PQ-)LQ\X4<R]Q6[CS=]8T+
M%(S4FSB&^5\?,31<)$>6JD:LTY6T>U>JIMCN3D`[CRD"I@/J.-05K_U<#34[
M]]TM4JJ%H!/4K/QDMN_:>G;$DZ5XML5%6+9=FPT#A,"0_MRPU;&R3"58LI"-
M>(/V#]HB]8O6IRJM7C1<A3HN6RI1$JB*I3`)1#I"E7+3K!ZEY)2\C!0.T$8$
M1-:5H=2'&S-M0F#R@[([:JA$R&.<="E`PF'4``"E`3&,(F$``"E#41$>`54+
M3,-)FI1W",90IXG$)2G>8BCW5=\3LFVNSCJTIJ]W^1[\:$6(YM;&<8:Z"13Y
ML82FC[DE&C@B$&XXZZ&*H(>#7723=*<(M;:H:#M!3AFVJ5+K'3DGRE(/G`8=
M^-3O6M+%I\EBH?0NJ"9Y$XF1V;#OE$55Y^<OQY7;AO8FU5^\:@(>33,]?K9J
M=4H:^KAQ@^=(1#3I4&I@H_5=JJ=05=[DV4J$P&DX@\AQ,1V_QK0I9%!1J4@'
M$J\GO1Y6/G*F6P__`#C:_$1T#VQI\`UX`(^2]05[Z/5HLBDR;KZA2QMDG9&#
M^=%4=M&E/2K;&GSE7+?R<;7]\:?X)5W],UI^N5/H_ABG\YZGZLWZ4'SE7+?R
M<;7]\:?X)1_3-:?KE3Z/X8/YSU/U9OTH/G*N6_DXVO[XT_P2J_TRVDX&MJ?1
M@_G+4J\GLR,?QHO=[O+OGL@[V=SMMX)N'#T%947,0D]+J3;&6(^=)J0\<Z?I
MHE2!!,0!4S8`'CT#4><4^!U'H;3B[W1U+KR4O($E)PQRB-ET/Q&K-2W55`I@
M(;$\9<D7M=ZKO^N;N^<6XIOVV+"CK^=9!R,[LEVPD7Y6*;!NWM:3N`'J2ADU
M`.<56`$TT#@;6H^X3<-*7BA>JNDJGU4PIZ/,#R_&@>W'O:[U<-%T%/5%'6)<
M>4-D]Q,0D?.5<M_)RM?WQI_@E,$CU9;2$@=MJ9`#W,1V.-%01,4R)'\:)TN[
M!WQW-OTPY<V5+GLF.L5W!WK[64(R.>E>I+-BL%7(N#J%33^R"<H!T=%+YQ3T
M`GA[?$T++BG6G6,X*ML@H`S&Z)+TAJ0ZIMRJU20@I=`(&P=V)-4PT`1\(U&(
M2$DD';C&ZJ2$K,C.9G')5T4@H@@H@@H@@H@@H@CC45(D`"?4`$=-0#_ETT01
M!'WF/?)6ALRNAYA7%=OM<D9U*R*ZG%7@\MI8_!R0!;(RYBF$):9.0Q%#,0,B
M<B)BG$WC:!.?"_@W<-=V]=YN[G8M/-JD%'SW#RI&],1MK+B):M,OBUL?'7-0
MGE`F`>0Q!M9WG`.^*W[I-.3\%@RX(AV\37E86,QVK`/G;5,X"+9K+^V!T#15
M1(.7G,FH`&'F$!Z*G.N]7G2M5;6Z9BJJFWVQ@M2LR5?W9"7?B+J'BO=6ZQ3U
M4PSU9/F@>4(88VH[T-OO>^X.R#BBY(J;QW<Q2Q:>0L9,+@*C<36.,[;*M+@M
MRXBLP!]#*OR%2.H5N'(?F)U:TN.K=#:GX07VGNB"W4TA)++H3-&83FE8GM`Q
ME/$1,>FM36S75M>IUS:?3@43DHB6T<W/RQ"/:VS/'?\`0-SJ:P3W83*F7=P]
M][;[<+*S1Y&$-'6-EZ3?6I_!?D+<32;A>$;E<N>TT5`QO%#7A.(XA7(:[M;=
M>AC[):MR:EY21(I4MK$9IX24<!*-!1I>C9TW54[*G"^Y694CE,Y^"+G<'WG>
M.:MX^R7.=TP?M:M_;'?AMC!CF8JLQN6Z(K#-P2-W3+5N;F$[*,NN#59E5UY=
M-`K5[O24%HTM>K)3N)7679A5SGGF$H[2E*6^99"@J7)'OT;3URN-%=>K6@4+
MJ::1$LR<DU+YY*$H:F3+R<H`'4`"`CJ(:<-/1TI6_.>*UX+D!*)84@%Q;Q/E
M*(PCFJ^+8Q7=ZW7+7Y>=TWK/+K/)JZ9EQ,R;U=05%7;IP1(AUE1'4><Q4@Z?
M!76>@H*6V4+-MHDY*-A.5"1N$)'>:SM]4NM)G4N^<K>8IK3AIJ-?3E3FS>ZC
MSD)DD<L;3DYRB3AX_BB!O4B`\!U\`>C5[9+3I?1@X=I@R)D<,2J?/.'C^X5W
M5N,V[2T\2W'+*/KVP`_3M<$W)A4>N[(=*":#EUUCB8Z@G?++H%UX@1`.JD']
M8#1R;!JU-SHV^KH+A-R8V9TXK$MT\._#4<,KXJZ6--/4KSU3(D9^]&R)VPZ_
M3J`P"!(XF)$!GCNC6JQ6-IO3$/2^K5JG$MR*MDX"M*!F7BD19GW@.?D=MFS_
M`#KE=.1!A,0=G/8RWU"B'E83MQ&2@8Y1B34#'=,UY0JX"&O("?-U5N.A+`K5
M.LZ"PM(SM./)*^3(GRC[`]F/'U-<FK-8G[BLR'5'+RS.`\,8VIU(24J]>2\R
M]<RDY+.%)&:DWBAUG4A*O!%Q(/%U5!$RBSATH<YAZ-1X`%=0ETC5NITT-.`E
MEK*$)3L`E"7U2JFO*ZI2SG*S,[R(X1`!Z:``E68;9Q:?*0&SY@CC6`026$HB
M4_9&`IP'0Q1+H<ABCU&(H0!`>H0J\*GF!EY>!YP8!Y*^M3@X-\9%'NH,@S&2
MMAFWR=G5UG4E%6D%I&=+F%15RA;(-XU!98YM3**&3)ZH>(US2XNVRGM&O[A3
M4:0BG*PL`;`5^4?9,.!HFK?K-+4U14',]U9Q/,9#V!$:'?N]XM<>%8-IM,PU
M/2$!D:^HAO,9'N6.-V#RVK&D"J%:Q+!SH)R/;I;F.(')H*141`=>;A)?`'A?
M3:DN3FI[NTERSL$I2E1P4X-A(YC&I<3]6*L]`U:J)PHKZB1F-H2=O1"<9EEC
M=H=5==<ZI^T65<*G<+*J\PF[51=8RBRBG,<1U,8>FG@IZ9+:31LH2'$("4@"
M0PA9GU]4XIYTE94HXDS),<*BJ:(&%412`I>93F`0!(/\+H`\@C6!Y"6D!=?U
M:'488J`G`$U#H"D-JR\R28X@<H"`>.;334/$/Q`>C]K6%JKIR"5.,]7N\L=V
M,[5/4*)S,K/]P^.-?*&_]\-_:'_J5E[72?*->F(S]D>^15Z!\<'E#?\`OAO[
M0_\`4H[72?*->F(.R/?(J]`^.#RA`./.;AQ]0?\`J4&LI`)]8UZ8@%(]\@ON
M(/CB9ON$E2*]XI8G)S#RV;?`F\4^A0&W9,`U$0T`!'A4%>L'44RN'KS390XZ
MJI;."P=Z=T29PJI*JGO76NH>0@G>,.[S1,#YS"`?T<MLVG[;/TH.H?%M<?$!
M]*HG]5P#^)+F#NMH_P!9'C,;CQJ2DVBB!&`J%2]$PG7IZ=.H)$"%XRI.)`F8
M=.\W*X[1L@?&T?\`)*U([ZRRE#6%.-W8O\4,KP@0G^'W!+!3YGWH89#KI<)`
M)$N01*X2$C"-U$$%$$%$$%$$%$$%$$>![F\V0>W;!62\RS[]LQ;6/:DO*L#.
M^7LWLZFU4&$BR$,(`JM)ORD2(3I,8V@5[&F;+5:IOM)8Z$'K'JE*5'\0$9CT
M2)CSKE<F;=;7KDZ0E"&S@>43E&,\ON]9_)=[W;D2ZI-],W%>=PR]PR,E(K&7
M>K&DWR[ENFHH;H!JT.FB4NFA2)@'574JUVJCLUK9LU(VE-&PVE(3NF!B>Z9F
M$NK*E5==7;PX<U6ZI1S'D)\44KH%>DA1;GEEC'Q=2WFSR\HF<7G]WSN7F-IN
M[3$V58YTJG#+W$PM&^&7.)&CVT+D<I1+U=Z74"+EAO+CNTRCH('3`0&H^XFZ
M31JO0]=;0D*J0@N-<H6@9L#NG*4;;HJ[(T_J.GK"HA#JLB^21V3C(G05B8Q?
M1$4ZA;2MP8)R]3O:%\FCT2MCR,R3UQ3N)$A0`OE[TKKM15]4)C:]-<U3<+D7
MEI?<=#B$]203CE299>C"&Y%/2+"%(0G*E?6)PPS*$I]XQ]PN/K&3\F%*TH!$
M6<TXN1J9&,;)"WN%V58CJ;3[,A0"4<%<'`ZWJS`<=1XC5QN%<9S=6<R`DS/N
M1L3T8;(SI0A+8:2`$!15*6\[3TQ5^@:Z\1'PCUU\61,Y[XKE!,]\:U=%8Q2_
M177*$02TE.\GIBI;2M*;O:4=0]OMP=R+6#EYX6P#HHNTA42+NB(ATF6$APY2
M]=?'55U/0M+J:HY:="TI)_*CZZ1ARLJ^RLXG(2.Y%-<>(&*)#%,8AR&Z2'(8
M2'*/HE,40&OI;5G0%\HGW]GL1ADI/DK\\8&)HNX>W`-L-[Z(NSYA^$=;6;[2
MD;*D%55@(V4GHKM9"T6QB&$"F</Y9]V1-/&$:@CUA["J^:'[4V":JWNAT$;<
MAP7/FD,8DWA1=%T6HU4KA`I7VR,=LQLE#XH?MN(#H8P<.C4H\H_2$*0?`@%.
MPB&=RY0$B<@(UH@C:8`X:CII](>'7X:M<;#S9:.PRV;=NZ*B1\D@$&%4_.2L
MZG;LL%;<8F242-*K2V4;J:M%_$=L&@N;:91LJF41^Q%<JD<$(;3QB@:FT]5[
M3K2JBX:H>1,M!+#2CM"\"3Z((B$.,]W<33TEH9(R+4>L&_*`2/9`A4,="AJ/
M`-0U'P:B`#3?@$$J)*B>6(#43+#`<@BI96TYZ$MZT+IDV)VL+?:5P.+8=''4
M)%"V98L++JI\`#E;R!@(/HU\-%<J6O=<:8,U-*RJYC'T5E(_1H;4X,74YD\X
MBF%OM2OW,_UHUZ`VQ\\9!'N61Y>[TPEU\R]R!IIKTRB>NFGH5SDXZ'_^BUYY
MD?!$-OPZ\K2=,#LRJ^%"C?>^W4^NWO$]QCA\L=4(6?:6HV,KS"9-C;A7+>/0
M1U$0322(L8.7JIQ>"]"Q2<.Z!VGFE3[6=8W%1E,],+[Q'>=JM75*7C@R<B>8
M>.(UR!SK-T@Y=5W+9N43=`'<KIH$$?"`&4J4W7PRV7@5!Y`VCDD=L:$$YW`R
MKS4E,N<G;/EC(/=W+W=^"]LFWC'A)#'=I7)E>Y+6CYO(-ZST,TF)*3EYA$KM
M5J@632<I-HUHF8I42`3F#QA$PZ\.;G$;7U_U'J:K)JWDTC;I0A*5%(`2=N&\
M[X<C3%@MUNLK*&VP5K0%**@"9D#E&R)"O@HQ;^;3'P_[E6S[%UH0O%Y2D)%9
M58?YJO'*-A31TB=C3?HI\4'P48M_-ICWWE6S[%U7[8O/URJ^E7XXN[)2_)-^
MB/%!\%&+?S:8]]Y5L^Q='VQ>?KE5]*OQP=DI?DF_1'B@^"C%OYM,>^\JV?8N
MJ?;%Y/\`^Y5?2J\<4[)2_)-^B/%'>CL>6'"O"2,)9=IPD@D4Q4W\-;<)%O4R
MG`0.4CMBQ0<%*<!$!`#:"`\:POUU?5HZJK?>=:)!DM:E##I,7-4S#*\[24I/
M,`/`(7<\YAX;<MLH>#/LH'_UO<=,KZKWWGNO_'#_`%VXB'C3^R:/]85\$PG7
M3I)\T=$+P-D.F^;E?HCY`^-H_P"25J1OUE_OBQ^I?XC#+<(/V`OY\^"&&0Z1
M^A2YG8.@1*QC=5(I!1!!1!!1!!1!!1!"GWG'>Y^1`V)MIUO3"C=JXTRAD9DS
M7Y4I)D515K:L7(%(;FYF$K'J+B01`#`H&M-EZL&EFG:BIU/4(.="2TR3L"CB
ML[-LB`(@SC+J#LC#-BI%`+?)+GM`<@A5;70.KZ@>@&G4`=%-^I*^M0TC$KGB
M>:(%;4VRD"HF`,,/PQ7UPXQORU++L+(D_;[EA9>34'[FRIU34&\TE&K.&[L6
M^I0U[)9HH`Z"/17FL7B@K+O4V>E6%5-'+KA.9$P#AR8'?'HUM`_14C5:ZDAB
MI$VN@8&?=!CSU4A54E$SB(%53,03$,)3E`Y1*(E,&ABF`!X"'$!KT$K2N;H)
MZCW(Y9F1GRX1Y80,RE.DB2001N(,\(?2[D/>#(;G]I3>V;Q=F=9$P*\8X\G7
MBZA04EH-..1<6N_10-]F%!G#"@T.H81`5$QXZC7/7CEHM&C]:K=824VZN^,;
M`V`D^4/2F>[#<Z!OZ=0V)M+1!J6$I0J>_##V(F;`=?!H(5#JD@;-H,;J#,Y3
MM$:U9%T%$$8I>NN4(K$@7=80["X-^F`H&5;D>14Y.O(F49J%`Z3J.>IH).4%
M2&U*9)0H@`@/347\7%+9X?71U"BAQ*4+!'XI)EW8VOAVE"]9T[;@S(6VI,ND
M2GW(\7WD8`F-L.YW,N%I?F5+:UYS"\+)`0R;>8M^7=#*1K]HF<.<J(`]%+0=
M=!2&MBT/J:GU5I*CO30"75M(2M&W*H#*?!/NQ\^K[2JR:BJ*%/E4X4I25;)@
MXQX?85[R6-KXLK(L3VA9:P+LA;RC11.*1S/;>>I2#8@'#00$RJ`=/"MCN=M9
MN]NJ+2X`34-*;D1.84)>W'B6VM=IJUBI:P*'4GI$\8R=F$,AQ&6\18YR?!/"
M/XN^K0@K@1=$]2HX=QZ'K@4>KF1D2JD-IP$2C7*6YVQZRW.IM+\^MIWUH,]T
ME&7L2AVJ2H35TK=4@S2XA)]B/4J^*/HCKN%2I`0YU"I)@;F55.)2IIHE#F6,
MH<VA2$!(!$1'0`JU222"DXB?=)P'>.,5!`.<X`8QCAN\HSVYW&[ULYY"!VLY
MB6-T/;'MY$ZAU$&<;9;A2W52LBB(D3;OG,7VX\O`YC<W'6NFW"W3S.F.'=LH
M,H35.MEQ>&*G5C/,]"3*%!UU<W+MJJK<3^B;`2@3PP(G%D4;$N+@E(FW6AN5
MY<<O$VZR-X'T](M8AGPZ?\Y>%K>WG0Q3FM5_ZS;:EK/)E!/M1J=.VY55"*-`
M_P!PM03+I,HFQ[Z/"L1MV:;`</0[!".-:6V>?2G4$4RD[6[7-S0:ET/3@``(
MG>RY5#B(\1UJ`>`EV7J9.H+T5DA5U(0/Q`%9?8B4>*EM3;7[12$!/54!!(WF
M:=O/.(0%?M2GW,_UHTP0VQ%L9!#N6AT[O/"8^!>Y/RHG7.+CD<W$:M'+E'>3
M^"&SX>+ZO25,=ODJ^%">'>F_K"-T_P`9TQ^[*4ZG"'_K:TGEI@87K7BL^K:U
M7*Y%@S?_`#V,Z?\`2\/X-/\`2C6I$=4"RZWDSGJE;.@QJ*%)#[0PS=:G;TQE
M,<>CK8ME=?\`L=;`:ZZ_^3M:Y/W1*C=JPI!_]MV<\,9[N:'@HU`T3(;DJ32=
MAV816?'T/IU\.5SDCZ)K]Z8./H?3HRN<D$U^],''T/IT97.2":_>F-./5I].
MJ$+2"HC`">&V":_>QIJ8.D/V.%5!F@.`$)Y\#%R?*\U29SY86M\YA_1RVR_'
M]*?\-[CIG_5>^\UU_P"-'^LW$-\:?V11_/J^"83KITD^:.B%X&R'3?-ROT1\
M@?&T?\DK4C?K+_?%C]2_Q&&6X0?L!?SY\$,,ATC]"ES.P=`B5C&ZJ12"B""B
M""B"-!'0!&J&8&&V*@3,HIF[KP@[#MNX+RNIXE%VS:D*_N">DEM1391<8W.Y
M>N#Z"'BHI$$1\(55INIJ:]J@I4YW'L$<ZC@!WXM?6W3L+J'3)"-L8T/=GG.:
MW+;D,P9MF5G*HWM><LXAD'"QUDXZWF*P1D2S9`81*DS,V8%6*0FA0%01Z=:Z
ME:1TY3Z8TK06*DDA;#25+4!YZU#,HGGQEW(2_45:J_7JHN;ZI*6LY1.>4),A
M+O1YCC+&]SYCR'9N*+-0[>Z,A3S"UH@.0QTF[B6<),O+G($\8K1D*X**B`AH
M4!'4*]:[W2EL-F<OEQ.1BF0M4^>1D.['GVJA<NMS;M:$YPI<PKE/)#GG>7=W
MQ;TMW95JX_LR*:)79M%M1A=5JJ-NS31T81139+$3$`#J(.F7EJI`$1`%!`1U
MZ:1?A=Q$J:/BBY=+@LFENJUH<F=A4HA$^@9>_#)ZRTNW7:.%%2(`JJ)N:>8`
M`J([L^]"0R*@+HI+%`0(LBDL7F*(&Y5DRJ!P'P`8/3I]TL*80&CYFT<X.(,*
MXR)HDLYI8'GB8#N4MU+G;?O*@+:E79T\?YT;-\?724Y]46+\SGRBVY%%`1T%
MVYF>P:B;I[(X@%0MQ]THK4VB57!E.>XT"^L3RY/=#HVF)0X5WA%FO_4.+ZNE
MJ/)`W%>Z'ZBE,4=!$!`H"0=`$`YBFTX`/5PX5SXZQ,\GNSC[4,_)2%%!$PKR
MI].Z.2JQ=!1!&*7KKE"*Q(OW2GZP_;3Z-W<?1#5OPJ*N-K:SPRNSC9E)@>W&
MV<.OOK2]V)9?.1\!*1M[86W+Q$;_`))/M9#&-WOFZ/(FU4B0._@7$@<A0*9:
M3=2AD4S&\8>RTJ'_`%9+]UK-;II]<ZCR76A/:#M2!RB4\,,8D?C+;.KIF[PV
M`2KXM0`QG[XG9+V86!`HCP*',(\`*/0)AZ`'7PTV;:R'TOI!2XW,8\L04A.5
MH)'G9=O/#OOF^NX1'(VSI?#D@][2X,#W&YM]C&K.NV>^TV2[.28R@@H8ZH-S
MR\@Y2`!'I)H'"D,]8O3PL^MC=VA_M:]L.8"0#DRDIGLG@#W8:/A3=%773HIW
M2>T4ZR@DF>;`$$;P,98Q/7S:CH`"/#76H!)D9;]_,8DD$9<RC+&41R=ZAN=4
MVP;*LM7S#F*%W3T8I8EH("N1%=61NC2&?NVI^8H]O%1;Y5R73B!DPJ1^%NES
MJG6U'08*80Z%KPF)),P#TF6W=&L:NNZ;19:EQ<PHH*4F8$R1.?1C&.RU6.)E
M'3A5T[5,95X\7$17=/%!$[ITL)N)E7"XF.8>L1&NEBI-IZHID63)"1RRRSZ,
MN$)NI]]^;VUPK)*N[WXE2[FG;NVW#;Y\?HSD:28LS%+=7)EU,7*`JLU4V!E&
M$*FH8"Z%,C/+MEPYAZ2!I4/<;]6JTQP^?:8);K*MP-($\2%><1S`3!B1.&%F
M-XU=VER0;:1G$Q.9&[DG%^7G+',.XK;%S<O,?#=\*")0$!'FO:--Q]'6M&]5
MU*&M-7138E_O4@\Y*#CX8V;C.I?VM2%R12:4@`;O*$+<J_:E/N9_K1IFQM'3
M$-1D#^Y;_5XX4^[7)^5$ZYQ<;_\`L>L_*3X##7Z`^Z--^2KX4)X]Z;^L(W3_
M`!FR_P"[*4ZG"#_K6T?JJ?`(7O7'WJK/G/'%@9#"FL@N`%.+=PU=%(?FY#G:
MN$G!"G$H@;D,9(`'3CI4DR2I)2HJ`4D@D;9$2C3TI6W5)JDY3E*3)4Y8>.&'
M(3SCW=#!0\5"-L!8)7;0\:QBVRSAY?`+JH,&J35)5?LY@J?;*%2U-R@!=>BE
M@JO5FM%55.U2KB^%.N*7()$AF,Y;(F9OB_7-(#:*-H)"0-IW=V/J?.4MT_R?
M,!_OR^_9FL']+]F_>3_HCQ1D_G'</JC??/C@^<I;I_D^8#_?E]^S-']+]F_>
M3_HCQ0?SCN'U1OOGQP?.4MT_R?,!_OR^_9FC^E^S?O)_T1XH/YQW#ZHWWSXX
MT^<I;I_D^8#_`'Y??LS1_2_9]UR?]$>**CC'<`9FD;ETGQQ(%W:'?)9QWP;E
MV>$K^Q1BVSH)>V9:=-+VBZNE65!:.;N%B-^26D7+3LE#(!J/)S<>FHYXF<#[
M=H'3HU!25CC[A=",JQO,L<`,,8V717$&IU1?%43S"6\J"J?-R8;X^#YS#^CE
MMDZ__GV4_P"&UQUZ_JN_>:Z?\:/]9N,?&G]DT<OEU?!,)UTZ:?-'1"[C9#IO
MFY7Z(^0/C:/^25J1OUE_OBQ^I?XC#+<(/V`OY\^"&&0Z1^A2YG8.@1*QC=5(
MI!1!!1!!1!&AN`"/3H%6K)""1B9148&<0.=_5NWC<+[5PPK`RH)9#ST_1A!:
M(."%4C[":B"EU.I$I#]LBE*,%NQ0Y@`JARF#CI4]>KYI%=_UE]MU*`JTVT!8
M!$\R]R0=FW&(ZXE7UNW6842245=2K*G'9SGFZ(1Z*`$(0@"(E(4"%Z_%+P#3
M7P]-/T9$S&SP<W<A5"A<S,XSABKS=[:Z\OS/5[;F+@B2+VEB6"6M:T';MN55
MJZOFX"JHS`)"<HE!S$PJR"Q#AKRF,&G$*67UD]3BBLC&DVW#VBJ7UJP#+*VG
M8"-Y)!YHF?@Y9"JM=O50`:5H2;PQSG;([(<DDHF.EX:1A9QDVDXF78O8R6CW
M295$)"/D$U&SUDZ(;@HB\;JF(<.L##22L5'5H35M9FG6W`I)GB"DB1$NB<,1
M\4ZV?)P6D@@[P9S$8YOO'=K*FT+=ODG%+4%C6@_?N[RL%ZH@9!)Q;D\X&04:
M-B"4`\FA)!X=B00U+HB&E=+>%>KTZPT8Q7NJ_P!]3H"'`2"21L(EN(Y84;6^
MG3IZ_KIT%)I71UB"`0$@GS3/:9\F$611TM)P,A'3\"Z583T%(,IJ#?HG%-1I
M+Q3E*0C'/,''1!\W3/\`0J0WFFZAE=&]+J'T%"YB8RJ'X8TX/*IW$5*0HK9<
M"P`9&8.WHC)%=W[N0:;K-J>(\O$?$=S$A;+:#NT.U3.N%V6V1.&GG3E,@\Z!
MY*1:*N"`8`YB*`(<*Y>:[TRYI'6-;97!-L.%;:@"!U9,P!/I]B',TU>/MZRL
M7(8%2`%#?F'1%Z5:I'O0401BEZZY0BL2+]TG^L/VT_QO^JWJ+^-7_5MW^9'M
MQMG#O[ZTO=AS?O4=OY]Q6QW.-FM61I&<@8D<BVPS01%=T\G+'.O,L6#8"@90
M%7JB?)XO$==*2+A+J/\`A;7]!<W#)DK2A7)E7(0R^L;/]M:??I@`7`B:/RA.
M,=:D5=,#).`$KI!0[=R00$IDG3<PH.$3!P$#H+IF*/6`A72]2PZHO)V+\KTL
M83H!226UX+0HI/2#$Q/<=[B7>#=\]L6N]=%2LS.4([L.YDSJ@F*DFT%5]9OD
M_,($[8]P.R@;]L8G`-:@[U@-*IU!H)RXM)!J[<Z'>E!D".7"42?PNOAH;\BV
M*)#;Y)YI[,8??,(D$"Z".@B`^F'#]FN?2)@!:AY:US,,XM#:DJS&4L1WIPH3
MYQYN,-,7WAS:_#*D-&VPQD,F7:HBH'.2X7@N8*/BG!2CJ!`C%BN2@/6;6G"]
M5_3"J.EN&KEXOK<#3(.R0D5*[XET"('XR7=3BZ6SMF0D5KEW@#"R&@B/'I\(
MB&GT1&FS><6ZLO$?&'+ASS$_;B"D*6R5M@#J",#OARCS=';XG9^WO(>X23CP
M"9RW=AX6WGZA#)+HVG:R1XR29%Y@+VK9S/L^U`=!`1*&E(_ZT=_%PU93V!E?
M^VH&@H@;"MPSQZ`89/A!:NS6(W1Q,G7W"$G\4>/&+&_.6/TB]K_Q+7M_+2-J
M1/5@^ZUT_7D?`,:KQK_:M%^KJ^$(6X5^U*?<S_6C3.#:.F(:C(']RW^KQPI]
MVN3\J)USBXW_`/8]9^4GP&&OT!]T:;\E7PH3Q[TW]81NG^,V7_=E*=3A!_UK
M:/U5/@$+WKC[U5GSGCBP+73IUZN@!$>(Z```&HB(CU!4CJ4$(*U&24[8U)2L
MH&!))E(;<8J`MHWB8I3%LV\!*8`,4P6K/B!BF#4I@$(\0$!#B`]=?,FOMJDA
M2:FGQ_S$X=.,?8NAKFEE#C+H/Y"CMZ!&[VGWE[C+Q]ZEP>QU5[=;OK-/](CQ
MQ9V2K^2=]!?B@]I]Y>XR\?>I<'L=1VZW?6:?Z1'C@[)5_).^@OQ0>T^\O<9>
M/O4N#V.H[=;OK-/](CQP=DJ_DG?07XH/:?>7N,O'WJ7!['50U]N2"HU-/(?Y
MB/'%11U9(`:=F?Q%>*)JNX+@+ABM_,8XE;<N*+;?!_<I?*9."E8YMS'9/RE)
MY2\:(H@<1'@7FU&H(]8JNHG-`H88>:<=-0E4D*2K##D)B1^$M)5L:H6Z\TM+
M9:*9D$8S/-$I'G,'';EMDTZ/A]D]/YMKCJ+/5<^\MT_XT?ZS<;OQI_9%%\^K
MX!A.NG33YHZ(7@;(=-\W*_1'R!\;1_R2M2-^LO\`?%C]2_Q&&6X0?L!?SY\$
M,,ATC]"ES.P=`B5C&ZJ12"B""B""B".-0X$34.8Q4RIIG4,H<Q"$(4I1,)C'
M4$"%*`!Q$1T#KJT*G@GS]PY8M"TYI'9&.S[UO<^TW6;U,H7?!O0D+'LM8F-K
M(7*)Q;/H*VEE@/($1/\`8B*+R;IP4=`YA`@:ZUT<X,:2&BM"4^9/^[?:+[L]
MHS8I3S@`"%.XG75^\ZA=<F.RT>")':1O[L1UHD.J<J2+95TL<2IH-D"B=9=8
MW!)!%,@"=154WBE``'CTU+JF\F=3I2E#:,ZB2)`2GMZ(T9O,\IMML$NNF21S
MF,B?W7.U]QM.V;8HQY*D0&[YN(2O>^UVWB(K7'<)/*2`4AO'YT(<6R2G-QYT
MQZM*YD<5M5JU9KFKNC9*J-"^J;Y,B3*??G#B:/LS=ETZS0+!#P2%G#:I6XRY
M,(D1'E$-#!KZ`Z<>-1XKJW6BTL$)/((V<$RD0>\86Y\XJVQ-KSPK8^Y^!CE1
MN/#[TMK7:Y;(F74<6)<+DY6"!DTBF-JVN9\103Z<":ZB`!3&^KAJIJV:A?TW
M4K(IZIJ:)^_$A+O3B(>+MG55V=-SI4SJ&5#-^1M\,)O=)0$..H<.@>'A#IIX
ME@NH2VD^3,!1Y`(7,K!^,;Q44RETPQ_YN[NJ>61F2]]K%QOTQM7*C`ET6,BL
ML(+MK\AD03=L&Q#&!,K%Q`M5ESD3T,98`$0&ED]9K2++]L9UA0))>8<#;OS1
M&"^G/(=!B<>$5^2VX=//*\Y!6C\H;1WIPY20_,!>`ZB`"/TJ2W,/)Y%"8B>4
MD+S2]R9&-]5BL8I>NN4(K$B_=)_K#]M/\;_JMZB_C5_U;=_F1[<;9P[^^M+W
M8R)"I"'(8JA"J)',8JB:A0,0Y#*'`Y3E,`E.40Z0'76N;B\Y:&0D.H((Y<,1
M#@#*I!;,I%)C&T=X-@A[MMWB9SQ@X9JM(="]Y2=M%=5`6Y)6W;@.G+IR#4G*
M4#-A?OED@,`::IB%=..&FHV]4:+H+@%!50&4MK`W+3A(SWR`A/M:6I5HU`^Q
ME(;4HJ2=Q!Y(M6M&\9K'-VVQD.W%!3GK&GHF[(42F,0?72WWJ4JRU.30P)F<
M-B@;3I#A6W7*@;N5M=I'1FIWD*;4)3F%@IG(\A,:];[@+;5-W%L^6VH'^[/;
M[!C)F81S3$92P/C?-?EZ`P=SX\B;NDY`HD%L0[:(26N945"B)2HL7[=R`B`\
M.0:Y9WNUJL]^JK(X#UK%4IE`.U14?)ESG,(=*AJVZ^W4]:A0[*MD+4O=@)D'
MO1CO=\&>9'<QNPS=F*1+R$G[UDHB%136,HV1M^U%5+:B5$"<PID(_91::X\H
M!J8XC72'AWIHZ7T=06U0(<2R%+G(',ORB#+DG*%$U1=W+S>JFO5^A+J@GD"4
MDI'<,H\`L6R)3)E[V?CF$*H:6ONYH*TV(HD%11!2?E&D49X!"@(B5B1V*QNK
ME(-;5<+@W;;=47-1&2F:4X9[/(25`=TB4>+2L*JJUJA0)NNK2);Y*4`3W`9Q
MDS-O6'8'`&$,:X=M])%-C8%J14"Y5;I%02?S+-DBE-2H)IE*`#*29%5QX=*E
M<M=0WUZ_WJKN]2J=15/*6!.<@58"9Y-G@AV+7;&[90-V]G!"4)Y-PD3W?;A4
MSSEC](O:_P#$M>W\M(VF]]6#[K73]>1\`Q`O&O&Z47ZNKX0A;A7[4I]S/]:-
M,X-HZ8AJ,@AW+?ZO+"?HKW)^5$PKG%QPPXCUA.P%/@,-CP_25:1II>]5\*$\
M.]-_6$;I_C-E_P!V4IU.$'_6MH&\4J?`(7K70(U76`[>LBP9O_GT9PU_A:(#
MZ`R;0!Z.D!#AI4B5"$+I'D.8I+"^^!A&ILNJ8K&G&\5=8G`],90&PL>6`K9%
MFJ*6%9:BBMI6VJJH>UH0QSJJ1#43F,86`B.HAK7*.[U]6Y=JJ3U0$IJ%@`.*
M&Q1Y%0[E,E#](RXXA&8M)V)2=W/%6_!QCW\W]D>]6#]CZ\[M57\O5?2K_.C-
MV=GWB?03!\'&/?S?V1[U8/V/H[55_+U7TJ_SH.SL^\3Z"8/@XQ[^;^R/>K!^
MQ]':JOY>J^E7^=!V=GWB?03!\'./?S?V1[U8/V/JHJJN>+]3+YU?YT`IV)XH
M3+\A,=V/LNSXAR5]$VG;<2](`E([BX.,CG12F`0,4'#1JBKRF`1U#73C6:HK
M*M]`:<6XXWR%:B.]./I;0RRJ5.VA)Y0`/:A=3SF'AMRVR_']*?\`#>XZ9;U7
M?O-=/^-'^LW$-<:?V31SV]H5\$PG73II\T=$+P-D.F^;E?HC9!]#+1OR2M2.
M>LND_P`84YW=B_Q0RW"#]@+^?/@AAD.OZ%+E,%((Y!$K&-U4BD%$$%$$;3#H
M%!$Q**&4L3(1&9WL&[".VF[0,A3Z;T$KWR%'J8[QXQ3<%1>GG+C159*338@&
M*LJWM\BA55^7U('+X:D3A-I)W6&MZ.E4DFFIY.NX3&5!!(.[&4N_&K:QO*K-
MI=Y^4J@I*1RS4"`8QY6ICG554U%599=PL.HCSK.EU'*YS".HF,=98PB(\1UK
MI:H(``;&5I+80$[I`2A._CEJ6Z\HJ6X23W8]0PG>MO8US!C?(UUV\M=D!8=W
M0]UO;81432&=/"O$GJ$>NHJ<A2M'!DN57CJ)1KP=46RJOEBK++2N%IYYLH2Y
MCO$IX8R$;!9*^FM5<U7N("PT00GHAFDGG+,6D0B+?;&\3;HD(D@F%P)@":*1
M0323``7```A"@`:>"E5_I8N_[W8G^2H[><Q+YXR4BL31.SYER]N-WSEUC\F9
M[[X2?A%']+%W_>['H'Q13^<=']2>]/\`#'G^5O.%;/R]C6^L973M;7>0M\6O
M-VV[37FT'!$32T:Y8H/B)++F3%Q'K+E62'@)5"`("`AK7HVKU:]066O9NU-=
MF"[3NI5()5,@$$@8;Q,1BJ.+=JK:5RBJ*)<G$$>401L,N7?SPL("+=`>S:=H
M#8HJ%;D6'F62;E.)6R2Y@U`RR:`%`PAJ`B`CK3;A2U)2E9!4$`$R`QECLYX@
M9,UN+?(RA:R0GD$\(]%Q'DZ?PME+'V5[7>N8Z<L*[(6XF[MJH9)8K)B_;JS+
M<#D$IP*_ARKH&TZ04$*\F_VJEO=CJ[56)"F'V%(Q$Y$@A)]*4>G:KL[8[I3W
M-DR6VZ.;#8?8,9-G#N3K?S/B^P<J6P[:NH:_+4A+F;>1KD<I-%):/;O7$<94
M@B';QRRPHJ`/C%.00$`&N6-WM=39+U46RI!#C*RV01+S3*?093[L.=25#=>P
MU7LGXEUL$<\>F5\4?;&*7KKE"*Q(OW2?ZP_;3_&_ZK>HOXU?]6W?YD>W&V<.
M_OK2]V,B:`<Q=/\`"''H`=0!4PZ<?#7-W<.@>`0WVZ%;O.1]O$:ZM3#>Z&)9
M&2F8*96QO>T@4G.FO`2*1#VHBN8`T(H6<>K:&'B("`=5-3ZLVHG55U?I):I(
M<:#K4S*2D&:B)\H`V1"O&2TI-K:O:!Y;3@"I#:DX;H4I,74IBCT"`@/#70-!
MUX==.6HR?4RG]%U8'-F3Y1,+L\$K<FD?%K$@.0;9=\PPGMF[R!_BCNA\Q8I<
M2;<;]MN?=X@Q>S57*+Q:S+UCT'$^Z%,QO*"BQ)./#%,0!*`\O'4*5_5G#-B\
M<:Z.ZH01;'6@^Z9$ISM$\TIJ*4[=T3I9-6%CAZ^R5`.,R0!,`D'#`3F=NX0O
M4D0R:9"'4%0Y"E`RIA$3*F`-#*&,/$QCCJ(B/$1'C3-)67JIM`P97L'(`/P1
M!]4\1-`GE,O9,XFN[AW;:7.6]=K?LN0?:O@&W%K\7251!5M,S4DHI;T;&&.8
M!!-5BL_(\`.`CV7@J$/6%U9]B:%^R:02K*]PMSG(Y4F9/+(@$3YXE7A99V[G
MJ-5:X)HIFP0983P`$]D/;<H$*?F$1$W.<1$!XB8!$1TZ`U$:Y^&F*6V\I'6(
MVGNXPT*TEQQ+B#()$I0G'YRQ^D5M?^):]?Y:1M.WZL'W6NGZ\CX!A<^-?[4H
MOU=7PA"W"OVI7[F?ZT:9P;8AJ,@CW+)1-W>F$0`=/L]R"(^@$HF(USCXZ8\1
M:_H1\$0VW#G[J4WY*O#"?'>N,7,=WB&Z!%P!_P#*\@R$@B8Q`*3R5RHH9`PC
MP-JJ`>)U#H-.GPA(_EQ:I;>SB%ZX@??"M^<B/Q$P$=QQQ$`*25B3F$=="E))
MM3&,.FHZ%*`B-2,X1U#GS2O@F-*&-2S+Y1/AC*28JE8Z9QK8$I%/FDC&OK*M
MA=B_9.$G+5VW&);%*L@NB<Z2B8F*(`("/$*Y-W(*3=JQ*P0OM3F!P/G<AQAX
MZ"1H62,1U2?!'H&H>$/IU\<?7!J'A"B"1@U#PA1!(P:AX0H@D8!$/"'H<0X^
MEX:`1,=,5&V%K?.80'^CCMG4T$4T\^R@JF`!$A`-C>XRE$YBZB4.80T]&F>]
M5Y2?XGNN(G]G#?\`YS<0UQIQM%&1B!4*^"83JITQL$+P-D.;>;?S3!]M=R]#
M-U2F>0&6V)7Z8F+S)C(6Z9X@/+KS<IDC=(TD/K,9AJVF)\TT1$]WGPRW!X@V
M%:?==><-^SDAB\HAQXAU=8>"EK2/(3T1*QC=J'A"JQ21@U#PA1!(P:AX0H@C
M:<=`#00Z>G4-`#01$=>@-`"K'!Y!F9&71%<`?*&$(R=_;N?1SINW)B2`>'=6
M=MO:.K==:*_8OA`D$P&YS%*0YB*)IM@:$((:ZB4==*?'U<=+-6?21OU4F5RN
M!F@D;$#IY<86SBE?G*Z__9["IT5.F2Q/:HXSE/=$&O3Z-,)$3X'9&T#@/0!Q
M]))0?H\"CPJDT\J>^(KE7[U7>/B@YOZU7_$J_P!Q59IY4]\>.#*OWJN\?%!S
M?UJO^)5_N*)IY4]\>.#*OWJN\?%!S?UJO^)5_N*)IY4]\>.#*OWJN\?%!S>@
M</1,FH4/IF*`!K1-),@05<DQ/O0$*&T$=((@,&H<OAX"'3PZ]0JH<2WBL300
M?P>S&!^2FBGW1P',8<6\W1W/(7CAV_MK]P28>V+%$RK=EFLW*VKI_9ER*>43
M*Z8J&YU$H^X7I$2D#42@;4`Y0$:1[UC=(_9U^IM4TJ3V2L:RKD#(.(.4YL)"
M<IB>V&2X0:@<K[,Y::DCKJ98"9G'*<<!M(!Y,,893U#IU#3PZAI].END8E["
M,4Q77&8A%8D7[I/]8?MI_C?]5O48<:L>%MWE\B/;C;.'7WUI>[&1/+T#_9J?
MNAZYN;AT#P"&^W19_ORV]Q.YW:CF7$\DT.^>25J2$W:B"92B<E[6XT<25J*E
M`?5:3":0&#K*(UM^@K^_IC5]%>42ZIMT)7\VH@+'HDF/!U#;1=[144)WHGW1
MC&-<5:.8]T_BWI1*^B)&0AWQ3!H)7T0\7CGI1#J$KIL>NH#:FEH2ZS^B6D*'
M0H!0]@PF)3D=<0?<N$=XRC3G/R@GVA^R`X*=ES#R=H&GC@7H`X@&@CUAPJ_G
MBN!QCB5.!0,H;0I"@<YQ$>!2@41$?2"J*;6Z)-?IYC+TDR/L&,;[O5,*(VD2
MAX7N`-M9\/;27.6IA`R5T[@;C4N59%PGRN(NWK?24@(UFF<?&\FD?)".P+T#
MS@-(7ZQ.IQ=M<_8X_14+(:'Y9(4KVX:?A99A:M,I?WU`"O[=XQ/(?U!_[$W_
M`##4`GVQX8DI/G0FYYRQ^D5M?^):]OY:1M.QZL!'\+73]>1\`PO'&O\`:E%^
MKJ^$(6X5^U*_<S_6C3-@B<0U&03[E@=.[SPH(=(*7,/TI,E<Y>.?_8U=T(^"
M(;7AU]TZ;\E7AB`?SA#:C=-A;BF6Z2)C'#C&N6(>WK=G)!LES,[?O:"2<H%2
MD5@'F(M<P.142`0$![$W$*8+U==:43]@?TK5G_Y"E*G&^7JU;AT1%'&#3JZ>
MX-7UB?9WI)=EX?!"\H]`AQ#4.D?J4R:5(^+6E.9H`8?BQ#BF\B@E@^4V<.C=
M$MVT7OF=UVT;'<1B6';6IDC'5N=JG;,)>""B<A!LE3%,6,;3R"+EZ:-;B`]D
MB(`1/F'0.(U"VK^`>C]8W-^\H?<H*UT^5D`(*O?2)`,2-9>*NH+)3)HT4[+S
M"=ZU%)'1('"+V4?.4]P"1"E/MHQ2LIR@!U!O2YB<Q@Z1`@1`@77P!4>GU5[:
MA9/VS4A)V?%H/^*-N1QMK,@"J%DKWY5J\4<OSEC/WR8\4>_6YO8BC^EJV?OJ
MJ^B1^=%W\[*KZ@CZ17B@^<L9^^3'BCWZW-[$4?TM6S]]57T2/SH/YV57U!'T
MBO%!\Y8S]\F3%'OVN?V(H'JM6P&?VU4_1(_.@_G;5#'[/0?_`,BO%$A'=I]\
M5E/?1N&6PU>.&;&L2*0M9W/A-V]<<Q+/Q60[<"M^PD&#9$J9NRXB!M:C/BGP
M8H^']B8N;=>Y4J<=(`+:4@$=!C:='<2']5W%5.JB0S+;)9/=BY#ON=N%R;@]
MD%S*65%*SEW8HE4\BQ42V*!G+IJQ;':3RB)=0$190BJZY@`=>1,=->BO)X#Z
MHH=)\0&17R%+7(+:S^,J64X\X$>KQ'L_VUI>H9I?TC*@X.E$S"#22@*ID4_O
MA"GT$!`0$P`(@)3`!BB&O$!#4*Z)>2,$^;NZ(4^:CBOSCMZ8O)V:[Z\^[&;M
MG;EPO,19F%V)MD+MM.X8Y.2@IP&@D!NX!)7G!A)))$!(KE,HJ`F(EZ!&H^U[
MP]T[Q"ID4=Y#C=6U/JUHVR./AC8=-:PO&F:M9MJ0M)V@Q+TR\Y2W#-VR:3K;
M=BAZX*'V1U[;KB:]L;K-V"429,G'J`:A1SU6+,E4F;S5A/(6D8'D\[&7+$G(
MXU5J$R<H$%S?Y9&/1':^<L9^^3'BCWZW-[$5C_I:MG[ZJOHD?G1?_.RJ^H(^
MD5XH/G+.?ODQXH]^MS>Q%']+5L_?55]$C\Z#^=E5]01](KQ1K\Y8S_J4`VQ8
MI,8QB$*4+UN?F,=0P)ID+_`_$QU#``>B-5_I9MDBLWJH"4@DDLHD`.[%4\:Z
MA9RF@1,X"2R<=V$3VDWGWW8O=XR>\7<#C^&QY>Z]@.[LC\9,)%XZ2!Y,-C%M
M6!57?H-W(2KX>8QTA+H``'&E[1H6FN?$!&C[14JJZ=-0$*<*0,$GRE8&0ES;
MXE0WU]K38OUP2$+4W/+R3E(8],8^:[KIF[ZNVZ;VN5V=]<-W7!)W#+O%-3'<
M.Y%R=;F.(B(ZD1Y"?]6ND='0-V:DI;-3_P#J-,)2UT@8^S"?7"I-36U-:O\`
M]I3A/]V<>Z[/-OS_`'3;F,3X&:@Z(PO:X4372Z8B)7\=9D4HBO<TBU'Q0259
ML5>8#:A6OZ]U&-*:7N-^;(ZMMJ2)_*&<O9CV-*6G[9OK-O)P=VR]N,AQ%;+M
MJ,-%QD0CMWPLZ3BHUA&$=N\;VLJ\=$8-4FI5W;@S`5%W"W9<YSF$3&.(B(B(
MB-<YEZQU4XXIWM]:"I1,@ZN0F9X#-LANT6.SH0E!IVI@`>8G<)1W_P"B!M6^
M3CA#^;6UOP"J?Q?JO]X5WTJOSHN^Q;-]6:]!,']$#:M\G'"'\VMK?@%'\7ZK
M_>%=]*K\Z#[%LWU9KT$P?T0-JWR<<(?S:VM^`4?Q?JO]X5WTJOSH/L6S?5FO
M03%MN[ON]MON8-N>6,=65A3&5J7=.VE(KVO.6G9,#"S[:X8A(TO#MV,DR:(N
M6XR,@R3;FY3@!B*B`]->UICB+J2PZEH[M65M0N@:<`="UJ5-"CE(D2=QCS+S
MI2T7*UO,-4S?:,AR$)`DJ6&R,>)+0DU:\Q)VQ<C)2.N*WW\A"3S%8!*JRFH=
MXI&R;10.(`9!Z@<H\>D*Z44M93W&E:KJ4SI%MA39Y4K`7[<)Z_3]E?<IU"3[
M:RE8_&$78;$=Q\EM6W68@RZR>K-(=G=<;"WDU*HH"$M;,X<T,Y;/M!`/)&2L
M@5T.NH%%#7JK4>(FFAJW1]99Q^F+2EHYEH&8>"4>]I*])L&H*>X.?H<X0K\E
M1RGPQD?O;3;'M3]N?KVP]J'K*-Q^V/MB^MGM?[`'GKWV_J?(O(_LO-T<G&N8
M79[IVKL.4]IGU<M^;9*7+/=#A=:QFEAU4L_-EV[>2,69ZVS7N<N?WO3GL?76
M[KFO?,>DC\Z$9ZBN^1<^C/BB13NEV,JCWAFVQ5S"3K5$MVB8SAU!RS9NGQ;\
M55W#--$A0\(F"HIXS52$<.+K3]:T2I@8)6DG?N!C=N'J*AO6E)UJ"V)':@^*
M,B40=2Z^$Q^C[H:N=2P`J0Q$AX!#:]V?/LGW(VG$0*80`HB`"(`;HU#B&H>#
M4*P.%30+B2<QB@RAP%>#>P]V$/\`O?>[FOS;9GF\LO8XL2;D=O>2Y5:YFLK"
M,EI-A8EP2AP-)V_+@U!1VW%](]JZ(;LS%`'``(Z!K3]<&^)]OU%I^FLUWJFV
M[]3R:2E1EUB`)A9/+[GN0LG$'1%305[]?;FE.6UY1<(3N4<"`>3?*(5#+(E4
M%(5"`H74IA-JGRFTUY#%4*10I^K02AQJ>EN@NBG:2%GW1]R.@[XB5*G:?*H)
M*4@^:=L7F[+=C^5][V6H3'%FPLLRL\[QLK?M_K,'3:"MJVP.120-ZXN4DTU)
M%ZV`Z+8J?/\`9CEX@'&M%UQQ!M.@;6[7*=:57@$(0%`G-+##F,;QI72]?J2Z
M(*F%HI!(J5+R93C(PXKQW;F)<<V1C2TV_86]8UMQ-LQ7/IVRS>'8H,0>N!_\
M6^\G[54=1U4.-<U[M6/WN[/WRL455;[JEG^\3X)R$-M3T[-!3M4%./\`;H2`
M.Y%?*>H-H&O`>CT:\]P@)F=F'ACZ0)F4)Q^<K-9!?<1MA,SBY60*7"]ZE44C
MHR0?IIF]N<;H511DV7(F<0#7E,("/53H^K"Y3)TQ<\ZV1_OD>>L)]P>6%[XU
M,*5=*)2>N/Q"O-23[H<D+=*QLUV2G^SES_:S_P#MZ=_Z(_\`I],^'FI^<QZ2
M/SHA?J*Z7Z%SZ,^*,@5W+A54N[VPJDN@Y;*@I<_,@\;KM'!?X13'QD'!$UB@
M.O6`5SLXW5+55Q"N"Z?*2D-C#9,)D=D-OP]I'&-(TY7,'(I1GSG\&R+Y]P.W
M[&6YO%5SX<R[`)SUEW2F':HE6,V>QLBB10&4U%/"%%1E+,#J"*2I>)0$0Z!&
MH[TY?[OIJ[MZAM2LE6V9$2F%)W@C>#O$;!<K=3W>A525Z>L:6/)YN0],)8[P
M>XZW7[>IJ2E,/P$GN%QD===:.?VJ@W/>40PYC'`;C@E%6Z*"+=,=.T266,8`
M$=*=[1W'S2NHZ=JFNSB:"Z'!07^B)Y4G=/>)80N^H.$U[MU0X]:U=90GROQ@
M3M$N0;HB)N?&^2;+D%8J[,>WM`2"`@5=G(6O-@LD?42BF8S9DX0$P"'4>IJI
M+I:[@R'[?4TRF??9T*"NB9$HC1ZUW.D<+-2PZ%CE03WHI7ULF^NV[F#_`'=G
M`_U?7VIJ&MSU.OH+>'_E&(4U6/-8<^C/BC7UMFO<W<_O>G/8^K^O;]\QZ3?Y
MT5[/6_(.?1GQ0>MLU[F[G][TY['T=>W[YCTF_P`Z#L];\@Y]&?%!ZVS7N;N?
MWNSGL?5"\VH9<[&/XR!_B@ZBM&/4.?1GQ1.=YODSDD=\S]5Y$R\>D3&\CHM(
M1,DQ2.<RCPO(15VU13$X!Q$-==*7KUE'VW-&TM.E;:BFI]PL*EY(Y#$J\)J.
MI9U`_4.S;26Q@4$0\*^8M9-FX8OFJ#QD];.&CQFY("C=TT>(';N6RZ9@$JB+
MA!4Q#E'@8HB`]-(N)A04"0L;#O'0894A)!&!2=O(>F%2M_\`W`\Y+77<V6]F
M3N/+'RX/)J6PW//A2,TEC&,X=IV7(&25%4D@L8PI,S@BFES`0#"!=::_AMZQ
MC--;46?6;.;(0VBI3/,$I&49DC:<!-6T[91!NMN%HK'#7Z=.5<RI2.51,R`.
MG8(70R-M8W+8B=N&&3,$9/LQVU,<BJ4K;3E<3"F(@<4S11I$AB:]`Z\0IF[5
MJ[2=W**BWW*G<S)!`S@$=TRB'ZK3EWMZB7Z9]MT;2`8\2-%3I!Y3VU=)3!P$
MIK;GR"40X"&AXXIOV*V9=2RHS2MDB6TK0?9S1Y"F:U1GU3RCSMF<;?6V:]S=
MS^]Z<]CZMZ]OWS'I-_G13L];\@Y]&?%!ZVS?5;=S^]V<'_5]6FJI$+2JH=:0
MGF6@3[QBBFZM""2PYB/DSXHD6[KK9K,[O-VMA6I.0\JQQK8[I*_LENY.)?LF
M+V"A%452VPFN\;)?PG*N5DS$``'0$C<0"HRXKZ[I=%:4J54#J7;C5#JF@%!6
M4K!\K`[``>_&Z\/=+.7J]-"M0M%.T.L42D@'*1(3/*3$OGG"FZR2.%D;*;#9
M2J[&.;P-_P"45XJ$DW#=04"*%LR(:NV;15``2!%P+A,!X@8G-U5"?JVZ,IP_
M5:ZN"T!TJ4VTE;B9E2O.7(D3W1)7%F_/I8;T]3(=RE(4K*@D`CS1,;!S<T*V
M^MDUQTMNYM?`-O3@`(^C_!_13<JJ&<%+6Q)._,C#_P`H@(4]<53##A6?Q#CS
M;(;'\W?V:$CK?N_>3>D8LE/3*DIC[&+24:KM745$)%3]L4\W3<II+F2N)N[3
M0`QBET\G'0!I//69UL*NM9T3;7DF@2$K<+9F"3/`D<DHGSA+IH--KU$ZTM%2
ML%*0J>!YANAICJ#T@I5]F`V")OF>[&M$S!,P43,$S!1,P3,;1T*)3Z`(E'4`
M]$.-6E'6$3.P_P!O9@'6$@IV;#T0AEWW&S^9V^;NY;(%L6_*.<:YV1<7C#'B
M(YX_;QES`XY;H8O!8H+&2=R,HJLZ(!@T%,>FN@/`O7#&H](MVBI4V+C;AU?E
M$";1\T^41.6`G"O\4M-5-MU`;A1MJ51/C&0*O+VG9W8AJ5B9I5,Z?M=NDH'*
M8O,6WYT#!S%$`,`^M_241U#T:FY-13H6%N+8"`<?*0,#@1@J(U%-7J29-+$A
M.9;.X@\D,U(]X].N>Y,DK72]?_AEAKG@]JCY@:WIHK\+;N:&N"4BGJ919]NJ
MF;'%IO#'6`O(1<"%$=3A2G'AK0IXY)67FOL!:E5H5G3*:'$@HVR\]8'1,PP`
MU4__`"W+T_\`Y<29EE,\I)QV>]$-A_!GCGW!VC^(8_[S2F]OKOEG?25XXF?(
MCWH[PCL-,?6&P=(/6-F6RS>-5`5;.FL,R0<(*E]2HDJFD4Y#AIT@-8W*FI=:
M4RZXM3*Q)0*B01R$3QBG5-AT/A*0\!(*D)CH,5<``4``H`4`X``=`>E6",A)
M4<RC,F`0`>D`'4-!UZP\%$6D!0RJQ$=%_%QDHQ=QLE',9%@^;JM7;%ZV2<M7
M*"Q#$41625*8AR'*80$!ZJN;6MEP/,DI=&\&1[\4*$%LM$#JCNW19C+=V_L/
MG)A:?E=I&#GLJY7%TZ=FLB-(9VX$VHJNTB%*DZ5U#7F,`UN*>(NO4-)8;O%P
M33H$@D/*D/[<QCP7=)Z8?<ZUZ@I5N^^+:9Q=79&/+#QM;[2U<?V=;EF6XQ'F
M:0EN136*CVYN3DU3;-4R$*($X>E6L7"X5UU>54W)UQ]]6U2U%1/23'M4M.Q0
ML]11H2TS*65(`$N@16(%*'0`!Z05\?BC+(2`W"-:H0")'9%8IR6L^TYY9)Q.
M6S!S"Z!#)HK24:V>*I)G,!SD3.N0XD(8X:B`<!&L]/4/T:%-4BU-MK5,A)(!
M/*9;XM<2EY25N@*4D2!(G(<@CY?P9XY]P=H_B&/^\UE[?7?+.^DKQP9$>]3W
MA%2QD-$0C4C&'C&,4R2,<Z;1@V3:MTSJF`RAB))`4A14,&HZ!QK"Z^\^Z7WE
M*4\0`5$S)`V"?-`VA#+?5-`):,\!@,=L?1$H#P$`$/`-8PI0,P<8N3Y'F8=$
M:"FF80$Q"&$`Y0$Q0-XO@XZ@(5:M*7!E6)IBDAFS^ZY8Z+V(AY)$S>1B(M^@
M?3F2=L&RY#:=`B51,0U"KT+<;&5M2DI&X$B!0"_/`/3C%,_!ICD>FP[2_$,?
MU_\`8UF15U3<RAUP3Y%'QQ;U;?O4]X1I\&>.?<':/XAC_O-7]OKOEG?25XXK
MD1[T=X0?!GCGW!VC^(8_[S1V^N^6=])7C@R(]Z.\(/@SQS[@[1_$,?\`>:.W
MUWRSOI*\<&1'O4]X1]",LFS85T#V'M2WXMX!1(#N/BFC1P!3:ZE!5%,A^4=>
MCHJQVJJ:AOJGW%K:G.142)]!,52$H45H`"R)$@14]?/%8V`DF`:`F7341$-.
M&HCJ(^F(U1`#<PWY(/)%`E*59D@!7+&G9(]`H("'$!U12-J`CJ.HB41'4:JG
MR/-PBY1*S->/3%+O;"L62<'=O[-MAXY4^V+N(5@HJ<?"8YD1$1KZDUM8D22Z
MX!^4?'&/JV]R4]X1U/@SQS[@[1_$,?\`>:KV^N^6=])7CBN1'O1WA!\&>.?<
M':/XAC_O-';Z[Y9WTCXXM4RTL24E)'0(^G$6?:=O'75@+9@X55T)?*%8N-;,
MU%^4!`H*F0(03@`#UUC??>K9=K6MP)&&8DRETQ?G+3>1M(*.0#"/FR=DV')O
M5)"6L^VY*04,4JSU]%,W#E0P`(%`RRY#'/H'5KPJRGN:R`U3U!2V@2"1,2'(
M)1D*$O#KG)9SRX]$<7P:XX.`@-A6CH(B4>:!CP`?^YZ!K(BYU+RB&WGR4[\R
MA[<8^K;EYH[PBJHV'B89HDPAXQC%LD0T2:,&R35NF&NOB(I%*0OT`K&XZZZY
MUSJE*=(VDS/?@:`81U;("6YSD,!'?*<#<P``@)1T$!#0=:QQ6-U$$%$$%$$:
M"`#T@`^#7JH]N*A2D[#*/BR]LVY<!$4YV!B)DC<PG0+)L&[T$3&]49(%R'Y!
M-KQTK,U4U#,PRM:0>0D>"+<J3M`CX?P9XY]P=H_B&/\`O-9A<:\;'G?2/CBU
M332@4J2DI/,(U#&N.P3,D%BVH"1E2KF2"$8]D9<A#ID6,GV7(*I"*&*!M-0`
MPAUU;VVLS9^M<S@2GF,Y$@D3GLF!&/LU/ER9$9>20BMJ^6,\%$$%$$%$$%$$
M%$$%$$%$$%$$%$$%$$%$$%$$%$$%$$%$$%$$%$$%$$%$$%$$%$$%$$%$$%$$
M%$$=1\MY.T7<>-RMT5G!^4-3<C=%1<P%#PF!/0/3JQPJ2TI2/.EX2!!Y68!.
M$S"X%CV_O-[T')&>\KV/O7OS:KAC'.4[@Q;C/'6/VY!D5E[-<(I*W#=+;RA%
M5-R[.Y#F.;@N'0`<M,9='M&\*+/;;5<K2W7WJLI$5#KR]F58GD3@<1$?6NIO
MFI*RIN-%5=GH672REL"?E)VJ5S'HA@#&,'-6/C>TK9O2\G=XW#;=OM8^?O>>
M,5!_<;UDGRN9V1,<>4BSH-#'$1Z:7VXO)K;HZ[2(2RT\N;;:=H!W`<VZ-\1U
MR$`N$*RI\I1P$QM)YHH@^;\?Y#C;ZMO#V7\>S&0X2"ENQ18S+.7+;LJFB<C=
M_-M$50,DR9."ZJ<P@&@#QK[#;ZRB>;=N-,\BB4XE,RE0*IRY1O[L?,W6TE7U
M[5&^VMU*23(@Y)`[9$[XH'96KF%K@.W4L^9/L_*^1474QZZWO9\HWEH-VW&5
M?&9MPED`(@Z69MQ*0PZ%Y.4"#ZG6O3UK]BKU`IO3-.]36WXN2'$E*\0`J0.)
M!,X^2T*JV+6@75U+M<HJ\I.*=N&/1MCVJS\V8CO^X)BU+(R=95UW);X&&:@X
M*>92$I&@14R*@NVB*@J)%(J02B.@Z"`UXM5;+E1TW:*IAUME6"5E)ETG`1]C
M%=3U%2IAAUEQ83YH4"0=^R.W<N8,6V8,\%V9%L^W36NV:N[A),SC-B>':OEB
MH-%Y`BQRF;I.%C`4AAX"(T4]LN3S;988>=*\`4I)23TB<7+K*2G4>O=;2@>=
M-0!3_;GE'V;,OZRLC0+6ZK"NR!N^VWW/Y)-V])-Y.-6%,QB'*FY;F,F)BF*.
MH=/"OGN%)76QSJJMI;;H()2H$$)WD`[8OIJNDJ49F'4+;)DE0(,SR813-R9P
MP]9USQEEW5E"R("[)A1%"*MR3N!@VF'ZS@Y$D$FS$RG;*J*J'`I2@&HB.E7T
M]LN[[*JQMATT8."RDA,NF4MG/%CERH&712.NMIK%>Y*@#W([]_Y>Q?BM%BOD
MG(-IV,E)+^3,#7/-,XKRM<3<H)(%<G*90W-PZ*RT=MN-P)71LNN)3MRI)`YY
MC"+*FN8MZ@FL<:052RYC(*GN$54:Y8`D+[9#SD46WO6\LKZ^&>HA%>MQD07!
MZ+SF[$&QD1`P&UTT&OC#%5VM3*D+!*LH1(YP?R=N,?6'`H*5Y(0D`SGA+ICQ
M4N[';,:,5FRY\Q::(0EV\"M(A=D6+-*9=-W+MM%G6[;D*\7;,U5"DZ1(F8>@
M!KTOL2\![L_9:GKBG-+JU3RB0)V<I$?-]M6?+/KF<H.6><><=@Z<#%Q%>;'V
M040040040040040040040040040040040040040040040040040040040040
M0400400400400401QJD*H0Q#CXA@$IPUT`Y3`)3$-X2G`=!"@B:5#FBY!`5B
M)@PNYNXP/N+[N7+&1=^&S*20GL'W')%O3<QMQE%^2.73,H`7)>%OE4`$4.Q2
M."A.0`%MH;FYP,&C!:/U+I[B;::?0^NFR+ZA'5452D95!7N$NJQFD'=(3B+;
MW;;OH^X.ZAT^4FUJDI]@X@CW2DC"2^><5/WEV[]]E+:!M;C\'W+*VU';[KPM
M&UT[B9"9E+)65)F2+<\.DY*//'*OBN!0,<-3`!.&E6\+=`,T.J[L]J-MM=9I
M^G4M0]SG$\A`W@2G'VZOU$V_8Z)VB*A27!Q*<,%25M$]VW&+\\>[&-K>US%U
M]3N%<3P-FWA(XG>P5Q7FR6DU[CN9OZR@JY6FGSI\NFY<NG*RASG*F0VH\-`T
MJ,KGKO46J+NTFZU*G*/MDVVP`$)D1(``;!TQL=ML5IL++AI&0VI37EJ!)4KI
M)/+S1#9;&:KMP3W"DC=5ER3QA<5RW7)8R;2J1EW4FP;7_D*6MYXZCSF4%<'S
M=LZ,9(P&U*8`$.BITK-.T%^X^4]OK_*;0PEU0$@`6V<XS"6*9@9AA,83B.::
MXUELX:K>;65N%Y203B0%.$=\#9R1249$8NQOF'N^[KV.[==QUE7]`7G`67G^
MZY_%5Y6Y$WCC^^XV+:7%/75+S+E=C,JFDI!TY(N4H`4A]0X%`1SU?VN_:=04
M&M*J@=MSC:ETJ6W$*+:T*4$I0!BD2`F#X8S(;M]-<;6Y9J=]#ZU?'*D1,$`D
MDG;B3CS1=%<&VC$>Y'OHLOVOF:V_;I94!@:`NA:QY&1D"6K/2[R8&*:.IV+;
M.D"/S1I4B+-R\Q2D6*!A`P:@.I4VH[K8N"+#EM6ENJ-UZM+@2,Z$`!<D*.R9
M,C.<Q'UHM=+7\1*EFJ"U,"E#F2?DJ43E\H;Q("0CZO=R*I;;#=ZG8=B'<M["
MP9=UV7U8,"Y<+OTX!>/QP>=(QC_*%#BFP150`A$0X:%#I'C5G$5AS4J=*72M
MD;C7I;:=6`!GF]U>,M^4]^/MTZMBV&]T[0RTU,Z5I'O9-9O)[NR.UW3VQW"&
M;\#6KO0W%V>AE_/N9;VE<IM;LO:1DI1]9/D=RO%+?86R5%XU;QC=L5NDKV7(
M8`,``.H:A7R\7]75UCO[NB["OL^G*1L,J;0D#K%Y?*4O`E1G@")8132.GJ:M
MH&K]>4FHN;Z\Z5*).5,SER@2EA*<YQ9_+WA@_/>_3>].;N,:9ASS%6;&IXAQ
M!:-E8YNG(MLX](#`?+YM%K;SYFE"S[M\W%0IUN<PB;F`2](;TFWZ@L7#^P-Z
M0>I:1=5.KJ5N*2EQQ(7D#94K:C&92,9B>S"/&#])=M5W%5]0MYFG^*90D$I0
M<N;/+<N0D%<^R/0K.L'=5??<Q9,Q=&6ME4LU9.2IHD?9=TH/X/(=[X%A;V1E
MD;71*N!G_:'MMGR%(`\X)%$HB.E>745^E[;QGI[K6*INIJ*=*<R0%-(J5-Y0
MK;*6:,M,U>ZW0KJ*/K4U33ZB`K:MH*\TG?Y,50A>_<M#LWE<M-\$VAY,6=@+
M-E\*$B9\<DAG@]F7)'V[;KF$]>_*R3PPA)1-%]R]F9L"J_)H4`#R38^,W\>)
MMBJM?:)J6FIS)ZCLW6)*O*RRR3R33.<Y"<?5VK17V$:@4@ZV0!9D<_793(RV
M[E8PS%2]Q*<%$$%$$%$$%$$%$$%$$%$$%$$%$$%$$%$$%$$%$$%$$%$$%$$%
M$$%$$%$$%$$%$$%$$%$$%$$%$$=-^HLDT<+($,JLBBNJFD0!,991)%11-$``
M!$154*!>'6-5`GOE`-N.S^VSGA=C<SO\WHY8QUE_;C&]W+FS%LW=T1/V<_W!
M9'1?PF`[6M9P!VS^[YF[Y>TV%N1D<A'F%4'#AZ5N40U,/"F#TMH;3-HNE%J9
M=[H*NF:*'4TK+K:JQQT8AH,I67)DX8)F8C2YZEN]8M^S4]MJ6GRE0Z]U"DTX
M3[[.4A)Z,T;]R>V#'AN[3V@6+CS<1A,^4,%I6I<VWB\WF1+3;6GFRZH-TX?S
MUIX]EU)OR2Y7]Q.E`;MQCU'(@H0?%'4`K+IK55X/$B^5U;;;A]E5J5(JVNI<
MSTZ%"2%OC)-L)&)SA,8KS:*5>E*!EJJIA44S@4T2M(2\H8Y&S.2B3@)3Y(N^
MVZ;SLZ[C+)R/8>7=DV<MMSVUL1R1Y"_LDPLS%67=,\SC56J[:UW$G;4.DNU<
M]B"R*A5U2G(H&FNFM:#J31ECTY6,W&V7>@N##M<`VVPZVXZA*B,5H0M13EV*
MF-L;'9K[4W5#[=?155,IEKRBZA2$K^;*D@*'1.+"<0XCLC+_`''[K'E_9*L?
M%J3VXI^2M:]+UNZ!M>T$<@Q-]R[^R8M_<LV^91+,9B;(F@7F5`PB;0`$>%2=
M>[W5V'C@BXVZCJ*UWJ$(?:90I;I:6T$K5E2%$!"3F)E(`3,:?;[;2UO#U5**
MAIA)<4H+6H!(4'"0F9($R<)3VQ>-LRWW;C;TF<68#R_L(S;9,]%0*4%=N=U+
M;EV^&G*-O1J36)N*WIYW:J;"59W(BBF=OV+XP&`W.01(8M:#K70MGMYK+[:[
MS05%.5%:*=-0A53)9GD4T'"J:"2%>3A+'&-ETYJ.IJNHM]7;ZAJH`EUA:6&C
ME$@H+(R^5M$C&S%J*G_]K=P;KF;B4^VNRT`1[=,'10)=@B*IFVO:@D8O0;30
M1X5?6OG^25,C(O*;N3.1]XG#IBREIPG7]2^%H*S0H!3,3`S[9;8H;99`0DWG
M#O<(*Z)J+A;9N:Z9")GYQR^:(LH&"E<>(Q\O*2ZRRR2$:TC&"ZBZQUCD(1(@
MF,(%`1KV==/U#>E='OT:5FK;`6A(22I2T/E00D`3*E$!*0`220`(QV9AA5TO
MU,\M'4+7)2RH!(260#,SD`!,F9&$>"=W/N.W+[3;4M3:<&UG(.Z#"J%^/F.%
M=S^W]RKD##@8UFKJ<)C)S.0;9A+AM9^,8#HSA4J+XODY2&1.('((AZ/$?3UA
MU74.:O9KZ6V7?JYU%#5K2S5=<$3,F5J2X23A+).<>5IJ\W.U4[5F=I*FIHPY
M)JH:0I31;S&1SA)3*6PSE'"\O;)&QK?KN8RI@C&JN]G"6:%(\N1,<[=))G?^
M5,-Y+CRI@LK>UL6NTNJ6A!D`34[,KI!L)DSZZ#TUD<IZ;7>@K5;KPL6:\4+:
MDM.UI-,S5,E>UM3A;2H`R)()$40X[IS5%;6TB1<&:D@K0Q\:XRH"<E(1F*9C
ME$2D2>\S,D=M3A=Q#39#F]]>#^??L93;I',7B^5(FW6KURW2G%HEO:QWSA9X
MR2(OY-Y"!]%.4==!J+V='VJHU8O3C]VHFV4H$JI3J!3E<A@EPKRF1.!"]T;J
MN]U'V(+I343T\Q)9"%9Y8[4RG/FEOA;=IEI`V]*X.\!';]!IP*.6[0L4FQXM
MSVV;<"[FW.-;X:*947PR5E[8D+OCI1H4R30\1Y4JFZ45('9IG`6>7;+D-"-\
M->VNYC3..?:N4]F"0\W-KM?Z/*9C'K)81%8K6SJ`ZK[,.L$D]CF.N)*%>7U/
(GS$I2R[X_]D_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
